Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price fell 0.4% during mid-day trading on Monday . The company traded as low as $0.3473 and last traded at $0.3473. 234 shares changed hands during trading, a decline of 99% from the average session volume of 20,342 shares. The stock had previously closed at $0.3489.
Cell MedX Stock Performance
The stock has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.35.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
See Also
- Five stocks we like better than Cell MedX
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
